NCT02606357View on ClinicalTrials.gov

Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan

PHASE4CompletedINTERVENTIONAL

Enrollment

242

Participants

Timeline

Start Date

November 22, 2015

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

INSULIN GLARGINE

"Pharmaceutical form:Solution~Route of administration: Subcutaneous"

Trial Locations (1)

Unknown

JORDAN, Jordan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT02606357 - Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan | Biotech Hunter | Biotech Hunter